Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort

28 Oct 2022

Abstract excerpt

Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer mainly caused by asbestos exposure. Specific and sensitive noninvasive biomarkers may facilitate and enhance screening programs for the early detection of cancer. We investigated DNA methylation (DNAm) profiles in MPM prediagnostic blood samples in a case-control study nested in the European Prospective Investigation into Cancer and nutrition...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Medical Imaging and Pathology Studies
Share to Occupational and environmental lung diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36305648
DOI: 10.1002/ijc.34339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohortPMID 36305648Read ↗

Integrating polygenic and methylation risk scores for pleural mesothelioma risk stratification.Semantic proximity Read ↗

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic AlterationsSemantic proximity Read ↗

A molecular phenotypic map of Malignant Pleural MesotheliomaSemantic proximity Read ↗

Progress and challenges in Mesothelioma: From bench to bedside.Semantic proximity Read ↗

Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical OutcomeSemantic proximity Read ↗

Genomics and Functional Genomics of Malignant Pleural MesotheliomaSemantic proximity Read ↗

Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed SubjectsSemantic proximity Read ↗

Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaSemantic proximity Read ↗

DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.Semantic proximity Read ↗

Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesotheliomaSemantic proximity Read ↗

Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs.Semantic proximity Read ↗

Genomics and Epigenetics of Malignant MesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.